This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and ...

Blocking Piezo2, a protein receptor that senses mechanical forces in tissues, may be a new way to slow IPF progression, per a ...

A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

Rein Therapeutics, Inc. (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to ...

Eric Cannon, PharmD, FAMCP, discusses how LPA1 receptor activation promotes fibrosis in idiopathic pulmonary fibrosis (IPF) ...

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...